Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             36 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 An insertional mutagenesis screen identifies genes that cooperate with Mll-AF9 in a murine leukemogenesis model Bergerson, Rachel J.

119 19 p. 4512-4523
artikel
2 Auer rods in mature granulocytes of a patient with mixed lineage leukemia Dmitrienko, Svetlana

119 19 p. 4348
artikel
3 Autophagy is required for CSF-1–induced macrophagic differentiation and acquisition of phagocytic functions Jacquel, Arnaud

119 19 p. 4527-4531
artikel
4 Blocking ephrinB2 with highly specific antibodies inhibits angiogenesis, lymphangiogenesis, and tumor growth Abéngozar, María Angeles

119 19 p. 4565-4576
artikel
5 Blood consult: Therapeutic strategy and complications in the adolescent and young adult with acute lymphoblastic leukemia Nakano, Taizo A.

119 19 p. 4372-4374
artikel
6 Cell transformation by FLT3 ITD in acute myeloid leukemia involves oxidative inactivation of the tumor suppressor protein-tyrosine phosphatase DEP-1/ PTPRJ Godfrey, Rinesh

119 19 p. 4499-4511
artikel
7 Concomitant inactivation of Rb and E2f8 in hematopoietic stem cells synergizes to induce severe anemia Hu, Tinghui

119 19 p. 4532-4542
artikel
8 CyBorD: stellar response rates in AL amyloidosis Merlini, Giampaolo

119 19 p. 4343-4345
artikel
9 Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival Venner, Christopher P.

119 19 p. 4387-4390
artikel
10 Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis Mikhael, Joseph R.

119 19 p. 4391-4394
artikel
11 Deficiency of CD73/ecto-5′-nucleotidase in mice enhances acute graft-versus-host disease Tsukamoto, Hiroki

119 19 p. 4554-4564
artikel
12 DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses Harada, Yosuke

119 19 p. 4451-4461
artikel
13 Dynamic HoxB4-regulatory network during embryonic stem cell differentiation to hematopoietic cells Fan, Rong

119 19 p. e139-e147
artikel
14 Editorial Board
119 19 p. i
artikel
15 EUTOS score is not predictive for survival and outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single institution experience Jabbour, Elias

119 19 p. 4524-4526
artikel
16 Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells Duhen, Thomas

119 19 p. 4430-4440
artikel
17 Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome Zhang, Su-Jiang

119 19 p. 4480-4485
artikel
18 IKDCs or B220+ NK cells are pre-mNK cells Zitvogel, Laurence

119 19 p. 4345-4346
artikel
19 IL-5 promotes induction of antigen-specific CD4+CD25+ T regulatory cells that suppress autoimmunity Tran, Giang T.

119 19 p. 4441-4450
artikel
20 Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage Jacobi, Paula M.

119 19 p. 4543-4553
artikel
21 Margaritis P, Roy E, Faella A, et al. Catalytic domain modification and viral gene delivery of activated factor VII confers hemostasis at reduced expression levels and vector doses in vivo. Blood. 2011;117(15):3974–3982.
119 19 p. 4577
artikel
22 Monoclonal B-cell lymphocytosis: right track or red herring? Ghia, Paolo

119 19 p. 4358-4362
artikel
23 Mutation of the receptor tyrosine phosphatase PTPRC (CD45) in T-cell acute lymphoblastic leukemia Porcu, Michaël

119 19 p. 4476-4479
artikel
24 Progression in smoldering Waldenström macroglobulinemia: long-term results Kyle, Robert A.

119 19 p. 4462-4466
artikel
25 Quantitative modeling of chronic myeloid leukemia: insights from radiobiology Radivoyevitch, Tomas

119 19 p. 4363-4371
artikel
26 Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma Kumar, Shaji

119 19 p. 4375-4382
artikel
27 Redefining interferon-producing killer dendritic cells as a novel intermediate in NK-cell differentiation Guimont-Desrochers, Fanny

119 19 p. 4349-4357
artikel
28 Runx1 deletion or dominant inhibition reduces Cebpa transcription via conserved promoter and distal enhancer sites to favor monopoiesis over granulopoiesis Guo, Hong

119 19 p. 4408-4418
artikel
29 Sensing tissue damage Perreault, Claude

119 19 p. 4346-4347
artikel
30 Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies Agathangelidis, Andreas

119 19 p. 4467-4475
artikel
31 The FLT3ITD mRNA level has a high prognostic impact in NPM1 mutated, but not in NPM1 unmutated, AML with a normal karyotype Schneider, Friederike

119 19 p. 4383-4386
artikel
32 The miR-17-92 cluster expands multipotent hematopoietic progenitors whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in mice Li, Yanmei

119 19 p. 4486-4498
artikel
33 The tyrosine phosphatase SHP-1 dampens murine Th17 development Mauldin, Ileana S.

119 19 p. 4419-4429
artikel
34 Tsui NBY, Kadir RA, Chan KCA, et al. Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA. Blood. 2011;117(13):3684–3691.
119 19 p. 4577
artikel
35 Ubiquitous high-level gene expression in hematopoietic lineages provides effective lentiviral gene therapy of murine Wiskott-Aldrich syndrome Astrakhan, Alexander

119 19 p. 4395-4407
artikel
36 Zimran A, Brill-Almon E, Chertkoff R, et al. Pivotal trial with plant cell–expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease. Blood. 2011;118(22):5767–5773. Zimran, Ari

119 19 p. 4577
artikel
                             36 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland